A new human cell line with pre-B cell phenotype and t(5;12)

Leukemia

Volumn 11, Issue 7, 1997, Pages 1040-1044

  Ingles Esteve J ^a,c   Aventin A ^b   Azqueta, C ^a   Kadar E ^a   Bothner, K M ^a   Amill, B ^a   Limon A ^a   López, J García ^a  

^a Institut de Recerca Oncologica   (Spain)

^b HOSPITAL SANT PAU   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Phentotype; PMA; Pre B; t(5; 12)

Indexed keywords

B LYMPHOCYTE ANTIGEN; CD56 ANTIGEN; CD59 ANTIGEN; DNA NUCLEOTIDYLEXOTRANSFERASE; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN MU CHAIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 3; INTERLEUKIN 3; MUTANT PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN P53; STEM CELL FACTOR RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; BONE MARROW CELL; CASE REPORT; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 5; CYTOGENETICS; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKEMIA CELL LINE; LYMPHOCYTE ACTIVATION; PRE B LYMPHOCYTE; PRIORITY JOURNAL;

EID: 0030825380     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400692     Document Type: Article

References (29)

1. Yancopoulous GD, Alt FW. Regulation of the assembly and expression of variable region genes. Ann Rev Immunol 1986; 4: 339-368.
2. Osmond DG. B cell development in the bone marrow. Semin Immunol 1990; 2: 173-180.
3. Burrows PD, Cooper MD. Regulated expression of cell surface antigens during B cell development. Semin Immunol 1990; 2: 189-195.
4. Nishimoto N, Kubagawa H, Ohno T, Gartland GL, Stankovic AK, Cooper MD. Normal pre-B cells express a receptor complex of μ heavy chains and surrogates light-chain proteins. Proc Natl Acad Sci USA 1991; 88: 6284-6288.
5. Lassoued K, Nuñez CA, Billips L, Kubagawa H, Monteiro RC, LeBien TW, Cooper MD. Expression of surrogate light chain receptors is restricted to a late stage in pre-B cell differentiation. Cell 1993; 73: 73-86.
6. Loken MR, Shah VO, Dattilio KL, Civin C. Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood 1987; 70: 1316-1324.
7. Löffert D, Schaal S, Ehlich A, Hardy RR, Zou Y, Müller W, Rajewsky K. Early B-cell development in the mouse: insights from mutation introduced by gene targeting. Immunol Rev 1994; 137: 135-153.
8. Papayannopoulou T, Brice M, Broudy VC, Zsebo KM. Isolation of c-kit receptor-expressing cells from bone marrow, peripheral blood, and fetal liver: functional properties and composite antigen profile, Blood 1991, 78: 1403-1412.
9. Ogawa M, Matsuzaki Y, Nishikawa S, Hayashi S, Kunisada T, Sudo T, Kina T, Nakauchi H, Nishikawa S. Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med 1991; 174: 63-71.
10. Era T, Nishikawa S, Sudo T, Fu-Ho W, Ogawa M, Kunisada T, Hayashi SI, Nishikawa SI. How B-precursor cells are driven to cycle. Immunol Rev 1994; 137: 35-51.
11. Campana D, Sheridan B, Tidman N, Hoffbrand AV, Janossy G. Human leukocyte function-associated antigens on lympho-hemopoietic precursor cells. Eur J Immunol 1986; 16: 537-542.
12. Seeker-Walker LM. Prognostic and biological importance of chromosome findings in acute lymphoblastic leukemia. Cancer Genet Cytogenet 1990; 49: 1-3.
13. Marti F, Miralles A, Peiró M, Amill B, de Dalmases C, Piñol G, Rueda F, Garcia J. Differential effect of cryopreservation on natural killer cell and lymphokine-activated killer cell activities. Transfusion 1993; 33: 651-655.
14. Inglés J, Engel P, De la Calle O, Gallart T. Differential responsiveness of human B lymphocytes to phorbol ester and calcium ionophore based on their state of activation. Immunology 1989; 67: 359-364.
15. Petriz J, Tugues D, Garcia-López J. Relevance of forward scatter in aneuploidy detection by flow cytometry. Anal Cell Pathol 1996; 10: 243-252.
16. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thyocianate-phenol-chloroform extraction. Ann Biochem 1987; 162: 156-159.
17. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD, Roninson IB. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 1990; 87: 7160-7164.
18. ISCN (1991). Guidelines for cancer cytogenetics: supplement to an international system for human genetic nomenclature. F Mitelman (ed). Karger: Basel.
19. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory: Cold Spring Harbor, New York, 1989.
20. Jongstra J, Misener V. Developmental maturation of the B cell antigen receptor. Immunol Rev 1993; 132: 107-123.
21. Tsubata T, Nishikawa SI. Molecular and cellular aspects of early B-cell development. Curr Opin Immunol 1991; 3: 186-192.
22. Tedder TF, Wagner N, Engel P. B cell antigens: section report: In: Schlossman SF, Boumsell L, Gilks W, Halan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF (eds). Leucocyte Typing V. White Cell Differentiation Antigens, Oxford University Press: Oxford, 1995, pp 481-736.
23. Simmons PJ, Aylett GW, Niutla S, To LB, Juttner CA, Ashman LK. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine. Exp Hematol 1994; 22: 157-165.
24. Ratajczak MZ, Luger SM, Gewirtz AM. The c-kit proto-oncogene in normal and malignant human hematopoiesis. Int J Cell Clon 1992; 10: 205-214.
25. Baranger L, Szapiro N, Gardais J, Hillion J, Derre J, François S, Blanchet O, Boasson M, Berger R. Translocation t(5,12)(q31-q33;p12-p13): a nonrandom translocation associated with a myeloid disorder with eosinophilia. Br J Haematol 1994; 88: 343-347.
26. Wlodarska I, Meccuci C, Marynen P, Guo C, Franckx D, La Starza R, Aventín A, Bosly A, Martelli MF, Cassiman JJ, Van Den Berghe H. TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33,p13) translocation or its variant t(10;12)(q24;p13). Blood 1995; 9: 2848-2852.
27. Drexler HG, MacLeod RAF, Borkhardt A, Janssen JWG. Recurrent chromosomal translocations and fusion genes in leukemia-lymphoma cell lines. Leukemia 1995; 9: 480-500.
28. Wlodarska I, Aventin A, Inglés-Esteve J, Falzetti D, Criel A, Cassiman J-J, Mecucci C, Van Den Berghe H, Marynen P. A new subtype of pre-B-ALL with t(5;12)(q31q33,p12), molecularly and cytogenetically distinct from t(5;12) in CMML. Blood 1997; 89: 1716-1722.
29. Salvaris E, Novotny JR, Welch K, Campbell L, Boyd AW. Characterization of two novel pre-B cell lines (LK63 and LiLA-1): potential models of pre-B-cell differentiation. Leukemia Res 1992; 16: 655-663.